U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Selected items

Items: 1 to 20 of 63

1.
Comprehensive treatment of dementia with Lewy bodies
Brendon P Boot
Alzheimers Res Ther. 2015; 7(1): 45. Published online 2015 May 29. doi: 10.1186/s13195-015-0128-z
PMCID:
PMC4448151
AbstractArticlePDF–424K
2.
Monoamine Reuptake Inhibitors in Parkinson's Disease
Philippe Huot, Susan H. Fox, Jonathan M. Brotchie
Parkinsons Dis. 2015; 2015: 609428. Published online 2015 Feb 25. doi: 10.1155/2015/609428
PMCID:
PMC4355567
AbstractArticlePDF–3.4M
3.
Treatment of the later stages of Parkinson’s disease – pharmacological approaches now and in the future
Peter Jenner
Transl Neurodegener. 2015; 4: 3. Published online 2015 Feb 12. doi: 10.1186/2047-9158-4-3
PMCID:
PMC4429454
AbstractArticlePDF–305K
4.
Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial
Manabu Ikeda, Etsuro Mori, Kazutaka Matsuo, Masaki Nakagawa, Kenji Kosaka
Alzheimers Res Ther. 2015; 7: 4. Published online 2015 Feb 3. doi: 10.1186/s13195-014-0083-0
PMCID:
PMC4338565
AbstractArticlePDF–630K
5.
DREADD: A Chemogenetic GPCR Signaling Platform
Hu Zhu, Bryan L. Roth
Int J Neuropsychopharmacol. 2015 Jan; 18(1): pyu007. Published online 2014 Dec 19. doi: 10.1093/ijnp/pyu007
Correction in:
Int J Neuropsychopharmacol. 2016 Oct; 19(10): pyw031.
PMCID:
PMC4368861
AbstractArticlePDF–1.5M
6.
Involvement of Cholinergic System in Hyperactivity in Dopamine-Deficient Mice
Yoko Hagino, Shinya Kasai, Masayo Fujita, Susumu Setogawa, Hiroshi Yamaura, Dai Yanagihara, Makoto Hashimoto, Kazuto Kobayashi, Herbert Y Meltzer, Kazutaka Ikeda
Neuropsychopharmacology. 2015 Apr; 40(5): 1141–1150. Prepublished online 2014 Nov 4. Published online 2014 Nov 26. doi: 10.1038/npp.2014.295
PMCID:
PMC4367456
AbstractArticlePDF–756K
7.
New Medical Devices
P T. 2014 Oct; 39(10): 661, 664-669, 676-680, 715.
PMCID:
PMC4189691
ArticlePDF–2.7M
8.
Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission
Gretchen L. Snyder, Kimberly E. Vanover, Hongwen Zhu, Diane B. Miller, James P. O’Callaghan, John Tomesch, Peng Li, Qiang Zhang, Vaishnav Krishnan, Joseph P. Hendrick, Eric J. Nestler, Robert E. Davis, Lawrence P. Wennogle, Sharon Mates
Psychopharmacology (Berl) 2015; 232(3): 605–621. Published online 2014 Aug 15. doi: 10.1007/s00213-014-3704-1
PMCID:
PMC4302236
AbstractArticlePDF–940K
9.
Treatment of advanced Parkinson’s disease
Juan C. Giugni, Michael S. Okun
Curr Opin Neurol. Author manuscript; available in PMC 2015 Aug 1.
Published in final edited form as: Curr Opin Neurol. 2014 Aug; 27(4): 450–460. doi: 10.1097/WCO.0000000000000118
PMCID:
PMC4140171
AbstractArticlePDF–558K
10.
Elucidating the Role of Neurotensin in the Pathophysiology and Management of Major Mental Disorders
Mona M Boules, Paul Fredrickson, Amber M Muehlmann, Elliott Richelson
Behav Sci (Basel) 2014 Jun; 4(2): 125–153. Published online 2014 Jun 13. doi: 10.3390/bs4020125
PMCID:
PMC4219245
AbstractArticlePDF–273K
11.
Advancing Evidence-Based Practice - A Quarterly Compilation of Research Updates Most Likely to Change Clinical Practice
Indranill Basu Ray
Ochsner J. 2014 Summer; 14(2): 148–153.
PMCID:
PMC4052575
ArticlePDF–72K
12.
Effects of 6-Hydroxydopamine Exposure on Motor Activity and Biochemical Expression in Zebrafish (Danio Rerio) Larvae
Chien-Wei Feng, Zhi-Hong Wen, Shi-Ying Huang, Han-Chun Hung, Chun-Hong Chen, San-Nan Yang, Nan-Fu Chen, Hui-Min Wang, Chung-Der Hsiao, Wu-Fu Chen
Zebrafish. 2014 Jun 1; 11(3): 227–239. doi: 10.1089/zeb.2013.0950
PMCID:
PMC4050718
AbstractArticlePDF–988K
13.
Advances in non-dopaminergic treatments for Parkinson's disease
Sandy Stayte, Bryce Vissel
Front Neurosci. 2014; 8: 113. Published online 2014 May 22. doi: 10.3389/fnins.2014.00113
Correction in:
Front Neurosci. 2014; 8: 254.
PMCID:
PMC4033125
AbstractArticlePDF–1.0M
14.
The Role of Dopamine in Schizophrenia from a Neurobiological and Evolutionary Perspective: Old Fashioned, but Still in Vogue
Ralf Brisch, Arthur Saniotis, Rainer Wolf, Hendrik Bielau, Hans-Gert Bernstein, Johann Steiner, Bernhard Bogerts, Katharina Braun, Zbigniew Jankowski, Jaliya Kumaratilake, Maciej Henneberg, Tomasz Gos
Front Psychiatry. 2014; 5: 47. Published online 2014 May 19. doi: 10.3389/fpsyt.2014.00047
Correction in:
Front Psychiatry. 2014; 5: 110.
PMCID:
PMC4032934
AbstractArticlePDF–364K
15.
Sofosbuvir
Dennis J. Cada, Jasen Cong, Danial E. Baker
Hosp Pharm. 2014 May; 49(5): 466–478. Published online 2014 May 12. doi: 10.1310/hpj4905-466
PMCID:
PMC4062722
AbstractArticlePDF–355K
16.
Psychiatric Issues in Cognitive Impairment
Dag Aarsland, John-Paul Taylor, Daniel Weintraub
Mov Disord. Author manuscript; available in PMC 2015 Apr 15.
Published in final edited form as: Mov Disord. 2014 Apr 15; 29(5): 651–662. doi: 10.1002/mds.25873
PMCID:
PMC4380016
AbstractArticlePDF–223K
17.
Reverse microdialysis of a 5-HT2A receptor antagonist alters extracellular glutamate levels in the striatum of the MPTP mouse model of Parkinson's disease
Marcus C. Ferguson, Tultul Nayyar, Twum A. Ansah
Neurochem Int. Author manuscript; available in PMC 2015 May 1.
Published in final edited form as: Neurochem Int. 2014 May; 71: 36–46. Published online 2014 Apr 4. doi: 10.1016/j.neuint.2014.03.016
PMCID:
PMC4059615
AbstractArticlePDF–3.1M
18.
Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected
Antoniya Todorova, Peter Jenner, K Ray Chaudhuri
Pract Neurol. 2014 Oct; 14(5): 310–322. Published online 2014 Apr 3. doi: 10.1136/practneurol-2013-000741
PMCID:
PMC4174166
AbstractArticlePDF–10M
19.
On the Discovery and Development of Pimavanserin: A Novel Drug Candidate for Parkinson’s Psychosis
Uli Hacksell, Ethan S. Burstein, Krista McFarland, Roger G. Mills, Hilde Williams
Neurochem Res. 2014; 39(10): 2008–2017. Published online 2014 Mar 30. doi: 10.1007/s11064-014-1293-3
PMCID:
PMC4172996
AbstractArticlePDF–1013K
20.
Antipsychotic, antidepressant, and cognitive-impairment properties of antipsychotics: rat profile and implications for behavioral and psychological symptoms of dementia
Marcin Kołaczkowski, Paweł Mierzejewski, Przemyslaw Bienkowski, Anna Wesołowska, Adrian Newman-Tancredi
Naunyn Schmiedebergs Arch Pharmacol. 2014; 387(6): 545–557. Published online 2014 Mar 6. doi: 10.1007/s00210-014-0966-4
PMCID:
PMC4019826
AbstractArticlePDF–361K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center